Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-22-091574
Filing Date
2022-08-16
Accepted
2022-08-16 08:00:57
Documents
15
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A tm2223554d1_10qa.htm   iXBRL 10-Q/A 52798
2 EXHIBIT 31.3 tm2223554d1_ex31-3.htm EX-31.3 4527
3 EXHIBIT 31.4 tm2223554d1_ex31-4.htm EX-31.4 4473
  Complete submission text file 0001104659-22-091574.txt   303634

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cycc-20220630.xsd EX-101.SCH 3547
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20220630_def.xml EX-101.DEF 27209
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20220630_lab.xml EX-101.LAB 36875
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20220630_pre.xml EX-101.PRE 25831
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2223554d1_10qa_htm.xml XML 6401
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-50626 | Film No.: 221168529
SIC: 2834 Pharmaceutical Preparations